Cargando…
Identification of a mutation in the human raloxifene response element of the transforming growth factor-beta 3 gene.
The human transforming growth factor-beta 3 (TGF-beta 3) is an important cytokine to maintain bone mass by inhibiting osteoclast differentiation. Recently raloxifene response element (RRE), a new enhancer with a polypurine sequence for estrogen receptor (ER)-mediated gene activation, was identified...
Autores principales: | Han, K. O., Kang, Y. S., Hwang, C. S., Moon, I. G., Yim, C. H., Chung, H. Y., Jang, H. C., Yoon, H. K., Han, I. K., Choi, Y. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057605/ https://www.ncbi.nlm.nih.gov/pubmed/11641521 |
Ejemplares similares
-
Deflazacort increases osteoclast formation in mouse bone marrow culture and the ratio of RANKL/OPG mRNA expression in marrow stromal cells.
por: Chung, H., et al.
Publicado: (2001) -
Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women
por: Ha, J., et al.
Publicado: (2022) -
Relationship of transforming growth factor beta 1 to angiogenesis in gastric carcinoma.
por: Choi, Y. H., et al.
Publicado: (1997) -
Transforming growth factor beta 1 expression in gastric carcinoma.
por: Park, Y. E., et al.
Publicado: (1997) -
Metabolic characteristics and prevalence of osteoporosis among women in Tae-An area.
por: Yoon, H. K., et al.
Publicado: (2001)